Souhaitez-vous accéder aux communiqués récents ?

Canada invests heavily in R&D but lags in commercialization output1. Dr. Robert Cooper, top innovation scholar and Professor Emeritus, McMaster University

BOSTON, Nov. 11, 2025 (GLOBE NEWSWIRE) -- BPGbio, Inc., a biology-first, AI-powered, clinical-stage biopharma focused on mitochondrial biology and protein homeostasis, today announced the...

Appointment builds on recent FDA acceptance of New Drug Application for review and advances Cingulate’s transition toward commercialization pending FDA approval Company also strengthens its cash...

Microbot Medical® Commences the Limited Market Release of its LIBERTY® Endovascular Robotic System in the U.S.

KANSAS CITY, Kan., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company developing and advancing a pipeline of next-generation pharmaceutical products...

KANSAS CITY, Kan., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company developing and advancing a pipeline of next-generation pharmaceutical products...

Beghou Arc is a flexible, connected commercialization platform designed to help life sciences teams launch and grow more effectively in dynamic markets.

ACT-ion Battery Technologies, Inc. ("ACT-ion") today announced it has signed a lease for a new facility at 1200 Tappan Circle in Carrollton, Texas.

Lumanity announces the launch of its new Value Inflection Point framework to help biopharma accelerate access.

KANSAS CITY, Kan., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform...